AI-generated summary
The authors studied 12 patients with retinitis pigmentosa (24 eyes) after nine sessions of multiwavelength photobiomodulation, assessed four weeks later. They report a statistically significant improvement in visual acuity, while visual field changes were not significant and no adverse effects were seen on imaging or electroretinography. The authors state that larger cohorts and longer follow-up are needed to establish efficacy.
- Participants
- 12
- Who or what was studied
- Patients with retinitis pigmentosa (12 patients, 24 eyes)
- Wavelengths
- 590, 660, 850 nm
- Limits stated in the abstract
- The authors note the study was short-term with a small patient cohort and that larger, longer-term studies are needed to confirm efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 590 nm, 660 nm, 850 nm
- Power density (irradiance)
- 4 mW/cm2, 65 mW/cm2, 0.6 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Retina. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.